AMZN
Amazon.com, Inc.
AMZN has a slight edge over CVNA overall, supported by lower modeled downside and stronger modeled upside.
CVNA
Carvana Co.
CVNA offers stronger fundamentals, but that advantage does not outweigh its weaker overall profile.
AMZN Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Weak | |
| Healthy |
AMZN's revenue, profitability and balance sheet are currently healthy, but its cash flow is weak.
CVNA Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Healthy | |
| Weak |
CVNA's revenue, profitability and cash flow are currently healthy, but its balance sheet is weak.
AMZN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 22x | $267 | — |
| Forward | 27x | $267 | — |
| Cheap | 34x | $415 | +55% |
| Fair | 60x | $745 | +179% |
| Expensive | 102x | $1,262 | +372% |
Historical ranges are pointers, not guarantees.
AMZN has the edge over CVNA in the historical PE scenario, which offers more potential upside but is not a forecast.
CVNA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 34x | $70.84 | — |
| Forward | 35x | $70.84 | — |
| Cheap | 36x | $75.86 | +7.1% |
| Fair | 83x | $173 | +144% |
| Expensive | 113x | $235 | +231% |
Historical ranges are pointers, not guarantees.
CVNA's PE is in its cheap range at 34x. On analysts' estimates for next year's earnings, today's price would be 35x.
AMZN Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Strong growth | |
| Growth | |
| Improving | |
| Moderate | |
| Moderate |
Analysts expect earnings and revenue growth for AMZN, with profitability improving.
CVNA Forward outlook
| Metric | Outlook |
|---|---|
| Stable | |
| Strong growth | |
| Strong growth | |
| Stable | |
| Limited | |
| Low |
Analysts expect strong earnings and revenue growth for CVNA, with profitability holding steady. However, they disagree widely on these estimates.
AMZN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $9.87 | -20% |
| Q3 2026 | $12.37 | +75% |
| Q2 2026 | $12.43 | +89% |
| Q1 2026 | $8.36 | +36% |
| Q4 2025 | $7.17 | +30% |
| Q3 2025 | $7.08 | +52% |
| Q2 2025 | $6.56 | +57% |
| Q1 2025 | $6.14 | +72% |
| Q4 2024 | $5.53 | +91% |
AMZN has the edge over CVNA on earnings, with more consistent year-over-year improvement.
CVNA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.05 | -1.4% |
| Q3 2026 | $2.08 | +136% |
| Q2 2026 | $1.89 | +136% |
| Q1 2026 | $1.73 | +204% |
| Q4 2025 | $1.69 | +428% |
| Q3 2023 | -$1.22 | +$0.57 |
| Q2 2023 | -$2.51 | -$1.18 |
| Q1 2023 | -$2.87 | -$2.06 |
| Q4 2022 | -$3.15 | -$2.82 |
CVNA's earnings per share have climbed steadily: $2.08 over the past year, up 136% from the year before, and higher year over year for nine quarters in a row.
AMZN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $201.9B | +12% |
| Q2 2026 | $200.6B | +20% |
| Q1 2026 | $181.5B | +17% |
| Q4 2025 | $213.4B | +14% |
| Q3 2025 | $180.2B | +13% |
| Q2 2025 | $167.7B | +13% |
| Q1 2025 | $155.7B | +8.6% |
| Q4 2024 | $187.8B | +10% |
AMZN's revenue has grown year over year every quarter since late 2020: $202B last quarter, up 12% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 14% | +4.2 points |
| Q2 2026 | 14% | +2.3 points |
| Q1 2026 | 13% | +1.3 points |
| Q4 2025 | 12% | +0.4 points |
| Q3 2025 | 9.7% | -1.3 points |
| Q2 2025 | 11% | +1.5 points |
| Q1 2025 | 12% | +1.1 points |
| Q4 2024 | 11% | +3.5 points |
AMZN has the edge over CVNA on profitability, with a higher operating margin.
CVNA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $8B | +42% |
| Q2 2026 | $7.4B | +52% |
| Q1 2026 | $6.4B | +52% |
| Q4 2025 | $5.6B | +58% |
| Q3 2025 | $5.6B | +55% |
| Q2 2025 | $4.8B | +42% |
| Q1 2025 | $4.2B | +38% |
| Q4 2024 | $3.5B | +46% |
CVNA has the edge over AMZN on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 8.9% | -0.9 points |
| Q2 2026 | 9.2% | -1.4 points |
| Q1 2026 | 9% | -0.3 points |
| Q4 2025 | 7.6% | +0.2 points |
| Q3 2025 | 9.8% | +0.5 points |
| Q2 2025 | 11% | +3 points |
| Q1 2025 | 9.3% | +4.9 points |
| Q4 2024 | 7.3% | N/A |
CVNA's operating margin was 8.9% last quarter, down 0.9 points from the same quarter a year ago.
AMZN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$34.8B | -8202% |
| Q2 2026 | -$8.8B | -2757% |
| Q1 2026 | -$18.2B | -$10.2B |
| Q4 2025 | $14.9B | -16% |
| Q3 2025 | $430M | -87% |
| Q2 2025 | $332M | -96% |
| Q1 2025 | -$8B | -297% |
| Q4 2024 | $17.8B | -36% |
AMZN's free cash flow was −$46.9B over the past year, against $10.6B the year before.
CVNA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $491M | +60% |
| Q2 2026 | $187M | +$189M |
| Q1 2026 | $56M | -73% |
| Q4 2025 | $379M | +953% |
| Q3 2025 | $307M | -18% |
| Q2 2025 | -$2M | -101% |
| Q1 2025 | $205M | +147% |
| Q4 2024 | $36M | +$293M |
CVNA has the edge over AMZN on cash generation, producing positive trailing cash flow while its opponent burns cash.
AMZN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +26M shares |
| 1 year | +0.8% | +84M shares |
| 3 years | +3.5% | +371M shares |
| 5 years | +6.1% | +629M shares |
| Available history | +8.2% | +829M shares |
AMZN has the edge over CVNA on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
| Q1 2023 | — |
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | $3.3B |
CVNA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | -50K shares |
| 1 year | +3.3% | +23.8M shares |
| 3 years | +40% | +211M shares |
| 5 years | +123% | +408M shares |
CVNA has 740M diluted shares, up 3.3% from a year ago.
| Quarter | Spent |
|---|---|
| Q1 2026 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q3 2024 | $2M |
| Q2 2024 | — |
| Q1 2024 | — |
| Q3 2023 | — |
AMZN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.7x | Very low |
| Q2 2026 | 0.3x | Very low |
| Q1 2026 | 0.1x | Very low |
| Q4 2025 | -0.1x | Net Cash |
| Q3 2025 | -0.1x | Net Cash |
| Q2 2025 | -0.0x | Net Cash |
| Q1 2025 | -0.1x | Net Cash |
| Q4 2024 | -0.2x | Net Cash |
AMZN's net debt is less than a year of its operating earnings (EBITDA), after holding more cash than debt a year ago.
CVNA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2021 | 186.0x | High |
| Q2 2021 | 128.9x | High |
CVNA's net debt is more than 20 years of its operating earnings (EBITDA).
AMZN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 57.1 | Neutral |
| Stochastic | 50.0 | Neutral |
AMZN's weekly RSI is 57 (neutral) and its Stochastic is 50 (neutral).
CVNA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 52.9 | Neutral |
| Stochastic | 67.9 | Neutral |
CVNA's weekly RSI is 53 (neutral) and its Stochastic is 68 (neutral).
AMZN PE vs Consumer Cyclical Sector
| Metric | AMZN | Sector median | Relative |
|---|---|---|---|
| PE | 22x | 18x | 20% above |
| PE % | 4 | 47 | 43 pts below |
AMZN has the edge over CVNA on valuation relative to its sector.
CVNA PE vs Consumer Cyclical Sector
| Metric | CVNA | Sector median | Relative |
|---|---|---|---|
| PE | 34x | 18x | 89% above |
| PE % | 8 | 47 | 39 pts below |
CVNA is trading at 34x earnings, a 89% premium to the Consumer Cyclical sector's median of 18x.
AMZN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $253.6 | 5.5% above |
| 20 week MA | $254.9 | 4.9% above |
| 50 week MA | $242.5 | 10% above |
| 100 week MA | $229.6 | 17% above |
| 200 week MA | $191.4 | 40% above |
AMZN has the edge over CVNA on trend strength, trading above more of its moving averages.
CVNA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $65.2 | 8.6% above |
| 20 week MA | $67.3 | 5.3% above |
| 50 week MA | $71.3 | 0.7% below |
| 100 week MA | $64.7 | 9.5% above |
| 200 week MA | $40.2 | 76% above |
CVNA's trend is mixed: it's above four of its five weekly moving averages, and 76% above its 200-week average.
AMZN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $93.5 | $158.6 | +70% |
| 2021 | $158.6 | $171.1 | +7.8% |
| 2022 | $171.1 | $85.3 | -50% |
| 2023 | $85.3 | $151.9 | +78% |
| 2024 | $151.9 | $223.8 | +47% |
| 2025 | $223.8 | $232.5 | +3.9% |
| 2026 YTD | $232.5 | $267.4 | +15% |
AMZN has the edge over CVNA on returns for 2026, with the stronger performance.
CVNA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $19.6 | $54.9 | +181% |
| 2021 | $54.9 | $48.2 | -12% |
| 2022 | $48.2 | $0.81 | -98% |
| 2023 | $0.81 | $10.6 | +1207% |
| 2024 | $10.6 | $43.0 | +306% |
| 2025 | $43.0 | $87.7 | +104% |
| 2026 YTD | $87.7 | $70.8 | -19% |
CVNA's yearly returns have swung widely, from +1207% in 2023 to −98% in 2022. It's down 19% so far in 2026.